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As part of the safety assessment for transgenic
crops, the risk for an introduced protein to 
be a food allergen is considered [Codex
Alimentarius Commission 2003; Food and
Agriculture Organization of the United
Nations/World Health Organization (FAO/
WHO) 2001; Goodman et al. 2005; Kimber
and Dearman 2002; Mendelsohn et al. 2003;
Metcalfe 2005; Metcalfe et al. 1996]. Because
no single assay or property can distinguish
allergens from nonallergens, a weight-of-
evidence approach that holistically considers
multiple lines of evidence is used to estimate
the risk of allergenicity (Codex Alimentarius
Commission 2003; FAO/WHO 2001;
Goodman et al. 2005; Mendelsohn et al.
2003; Metcalfe 2005; Metcalfe et al. 1996).
The allergenic nature of the organism from
which the protein was originally isolated is a
primary consideration. If the original source
is known to cause allergy, then sera from
patients allergic to the source organism are
tested for reactivity to the puriﬁed transgenic
protein. A second major consideration is
whether the transgenic protein shares signiﬁ-
cant structural similarities with known aller-
gens. High structural similarity with a known
allergen may indicate shared epitopes for IgE
antibody binding and a potential for cross-
reactivity and elicitation of allergy (Aalberse
2000; Ferreira et al. 2004; Goodman et al.
2005; Jenkins et al. 2005; Metcalfe 2005;
Metcalfe et al. 1996; Stadler and Stadler
2003). Three additional factors relating to
exposure level are also often considered: preva-
lence of the transgenic protein in food, stabil-
ity of the protein to food processing (Takagi
et al. 2003), and digestive stability (Bannon
et al. 2002, 2003; Goodman et al. 2005;
Kimber and Dearman 2002; Mendelsohn
et al. 2003; Metcalfe 2005; Metcalfe et al.
1996). To be useful as indicators of aller-
genic potential within a weight-of-evidence
approach, the relevance of each factor must be
understood, and the methods for measuring
them must be reproducible and robust. Here
we discuss the simulated gastric fluid (SGF)
assay and its usefulness in estimating the aller-
genic risk of dietary proteins.
Gastric Digestion Assay
Astwood et al. (1996) published a study that
suggested a link between the stability of a pro-
tein in SGF and its status as a food allergen.
SGF is a defined set of reagents held under
specific conditions (0.32% pepsin, pH 1.2,
37°C) and was developed to represent human
gastric conditions in the stomach (U.S.
Pharmacopeia 2000). Although a number of
subsequent studies have indicated a much
weaker link between stability in SGF and aller-
genicity (e.g., Diaz-Perales et al. 2003; Fu et al.
2002; Herman et al. 2004; Lee et al. 2005;
Murtagh et al. 2002; Vieths et al. 1999;
Yagami et al. 2000), the resistance of a trans-
genic protein to pepsin digestion under acidic
conditions is still generally accepted as one fac-
tor to be considered in a weight-of-evidence
approach for assessing the allergenic risk for
transgenic proteins (Bannon et al. 2002, 2003;
Codex Alimentarius Commission 2003;
FAO/WHO 2001; Goodman et al. 2005;
Mendelsohn 2003; Metcalfe 2005). Although
SGF assays may not actually mimic in vivo
digestion, the stability of a protein in SGF is
believed to be related to resistance to prote-
olytic processes that are encountered within
the digestive system and/or the intracellular
environment (Bannon et al. 2002, 2003;
Dearman et al. 2002; Goodman et al. 2005;
Huby et al. 2000; Mendelsohn et al. 2003;
Metcalfe 2005). Logically, some level of
in vivo stability must be required for a protein
(or a digestion fragment) to interact with the
immune system and induce allergy.
Assay Reproducibility
Because of the inconsistent link between 
SGF stability and allergenicity that has been
seen among different studies, the variation in
SGF assay procedures among investigators has
been scrutinized as a possible cause for the
conﬂicting conclusions (Bannon et al. 2002,
2003; Metcalfe 2005; Thomas et al. 2004).
Differences in pepsin concentration, pH,
protein–substrate concentration, and analyti-
cal (detection) procedures (SDS–PAGE gel
types, loading quantity, protein staining
methods, antibody sensitivity for Western
blots, etc.) have been considered major con-
founding factors. Because of this variability
among laboratories, there has been a general
call for the establishment of a standardized
SGF assay procedure (e.g., Bannon et al.
2002, 2003; Metcalfe 2005; Thomas et al.
2004). In response, the International Life
Sciences Institute conducted a ring study
using identical procedures and reagents to
evaluate the reproducibility of a standardized
assay when conducted in different laborato-
ries. This study determined that when this
speciﬁc enzymatic assay was conducted by dif-
ferent researchers with aliquots of the same
reagents under similar test conditions, a panel
of scientists could identify a similar time for
protein bands to become undetectable on
SDS–PAGE gels (Thomas et al. 2004).
Results validated the reproducibility of this
speciﬁc enzymatic assay and the technique for
detecting the substrate protein.
Assay Validation
A fully validated assay not only must be repro-
ducible but also must be robust and relevant
(Gerberick et al. 2002; Green 1996; National
Institute of Environmental Health Sciences
1997; Organisation for Economic Co-operation
and Development 2005). A valid SGF assay
must be largely insensitive to factors that
are likely to vary among laboratories. At a
Address correspondence to R.A. Herman, Dow
AgroSciences LLC, 9330 Zionsville Rd., Indianapolis,
IN 46268 USA. Telephone: (317) 337-3551. Fax:
(317) 337-3255. E-mail: raherman@dow.com
We thank V. Korjagin and B. Schafer for their exper-
tise in conducting kinetic laboratory studies that under-
pinned our research, and L. Tagliani, J. Mattsson,
P. Hunst, K. Armstrong, J. Cuffe, and J. Norton (all
employed by Dow AgroSciences, Indianapolis, IN) for
reviewing the draft manuscript. The comments of
M. Woolhiser (Dow Chemical Co., Midland, MI) on
the draft manuscript are also appreciated, as are com-
ments from the anonymous peer reviewers.
All authors are employed by Dow AgroSciences—a
wholly owned subsidiary of The Dow Chemical
Company—which develops genetically modiﬁed seeds
and produces insecticides, herbicides, and fungicides for
agricultural applications and residential pest control.
Received 1 November 2005; accepted 10 May 2006.
Digestion Assays in Allergenicity Assessment of Transgenic Proteins
Rod A. Herman, Nicholas P. Storer, and Yong Gao
Dow AgroSciences LLC, Indianapolis, Indiana, USA
The food-allergy risk assessment for transgenic proteins expressed in crops is currently based on a
weight-of-evidence approach that holistically considers multiple lines of evidence. This approach
recognizes that no single test or property is known to distinguish allergens from nonallergens. The
stability of a protein to digestion, as predicted by an in vitro simulated gastric ﬂuid assay, currently
is used as one element in the risk assessment process. A review of the literature on the use of the
simulated gastric ﬂuid assay to predict the allergenic status of proteins suggests that more extensive
kinetic studies with well-characterized reference proteins are required before the predictive value of
this assay can be adequately judged. Key words: allergy, digestion, risk assessment, simulated gastric
ﬂuid, transgenic proteins. Environ Health Perspect 114:1154–1157 (2006). doi:10.1289/ehp.8803
available via http://dx.doi.org/ [Online 10 May 2006]minimum, different preparations of pepsin
should yield similar results, and different scien-
tists should be able to interpret results in a simi-
lar manner. Furthermore, the use of different
analytical techniques for tracking protein diges-
tion should lead to comparable interpretations
of stability.
Kinetic Data Analysis
A great deal of literature exists on the conduct
and interpretation of enzyme assays (Anson
1938; Duggleby 2001; Jaswal et al. 2002;
Michaelis and Menten 1913; Noda et al.
1994; Park and Marqusee 2004; Rawn 1989;
Schnell and Maini 2000; Tzafriri 2003) and
biodegradation studies (Alexander and Scow
1989; Atkins 1986; Boesten et al. 2005;
Herman and Scherer 2003), including pepsin-
mediated digestion (Baderschneider et al.
2002; Boushaba et al. 2003; Bull and Currie
1949; Hollands and Fruton 1968; Swoboda
et al. 2001; Tagliazucchi et al. 2005; Tritsch
and Sachatello 1971). Thus, we incorporated
kinetic concepts into SGF studies conducted
by our laboratory (Herman et al. 2003, 2004,
2005). Rather than using a single time point
when a protein band was no longer visible on
an SDS–PAGE gel or Western blot (time to
disappearance based on the human eye), pro-
tein bands on SDS–PAGE gels were quanti-
fied by densitometry (Bindslev-Jensen et al.
2003; Brussock and Currier 1990; Cantu and
Nelson 1994; Syrovy and Hodny 1991) over a
digestion time course, and the pattern of pro-
tein degradation was modeled using a negative
exponential equation (pseudo-first-order
decline). Studies on the pepsinolysis of pro-
teins and peptides have often supported a
pseudo-first-order pattern of digestion (e.g.,
Baderschneider et al. 2002; Belorgey et al.
1996; Garrett et al. 2004; Irvine et al. 1983;
Matthyssens et al. 1972; Sachdev and Fruton
1975; Terada at al. 1974).
Exponential decline is one of the most
common patterns seen for biodegradation and
allows a single descriptor, half-life, to be used to
characterize the pattern of stability (Alexander
and Scow 1989; Boesten et al. 2005; Herman
and Scherer 2003; Palasanthiran et al. 1994;
Ramanathan 1997; Rawn 1989; Spiess et al.
1996). This measure of digestive stability is
independent of many of the factors previously
identiﬁed as variable among laboratories (e.g.,
type of protein stain, gel type, loading quantity)
because it measures relative amounts of surviv-
ing protein rather than a combination of the
absolute amount of protein remaining and the
speciﬁc detection level for that protein (binding
afﬁnity of dye for the speciﬁc protein and gel
loading amounts; Herman et al. 2003; Tal et al.
1980). Thus, a kinetic approach to analysis of
degradation results uses multiple data points
and relative protein decline to overcome some
of the shortcomings associated with observing
the first time point at which a protein is no
longer visible to the human eye (time to disap-
pearance). It is a standard practice to charac-
terize the speciﬁc activity of pepsin using kinetic
experiments (Anson 1938; Astwood et al. 1996;
Thomas et al. 2004), and we extended this gen-
eral concept to evaluations of proteins being
investigated for stability in SGF (Herman et al.
2003, 2004, 2005).
Digestion Fragments and
Protein Fractions
Interpretation of SGF results is sometimes
complicated by the appearance of digestion
fragments (large peptides). These fragments
may be more persistent than the parent protein
substrate. Because no minimum exposure
threshold has been established for food allergens
(Bindslev-Jensen et al. 2002), and because it is
believed that more stable proteins represent a
greater allergenic risk, researchers have focused
on the most persistent protein fragment when
assessing allergenic risk (e.g., Astwood et al.
1996; Fu et al. 2002; Herman et al. 2004;
Metcalfe et al. 1996). Similarly, when multiple
kinetic phases of digestion were seen for a single
protein substrate, our laboratory used the
slower, terminal, exponential phase of digestion
to evaluate stability in SGF (Herman et al.
2004, 2005). This latter approach does not dif-
fer conceptually from the time-to-disappear-
ance approach for evaluating stability in SGF
that focuses qualitatively on the terminal data
point (where protein bands are no longer visi-
ble). Thus, the most persistent digestion frag-
ment or protein fraction has consistently been
used to evaluate allergenic risk.
Assay Robustness
In addition to variable interpretations of SGF
data, researchers have also deviated from SGF
speciﬁcations (U.S. Pharmacopeia 2000) when
conducting pepsin digestion assays, including
alteration of the pepsin concentration and the
pH (e.g., Bannon et al. 2002; Dearman et al.
2002; Thomas et al. 2004). Also, researchers
have varied the initial concentration of substrate
protein that is included in the SGF assay (e.g.,
Bannon et al. 2002; Fu et al. 2002; Reed et al.
1996; Thomas et al. 2004). To investigate
variations in pepsin preparation (different lots
with differing purity and specific activity),
pepsin concentration, and substrate protein
concentration, we conducted a study in our lab-
oratory with two different protein substrates
and five different pepsin lots (Herman et al.
2005). Results indicated that variation among
pepsin lots, and signiﬁcant variation in pepsin
concentration (0.32–0.65%) and substrate con-
centration (in the low micromolar range), did
not substantially affect estimated half-lives,
although low purity pepsin lots (< 80%) had
moderately lower catalytic power (Figures 1
and 2). Likewise, similar half-life estimates were
obtained in a study where the initial protein
substrate concentration was varied 5-fold
(Herman et al. 2004; Figure 3). This is not an
unexpected result when one of the reagents
(enzyme) is in substantial excess of the other
reagent (protein substrate) (Alexander and
Scow 1989; Duggleby 2001; Boesten et al.
2005; Rawn 1989). In addition, results from
alternative protein-quantification methods
(chromophore or fluorophore release from
reporter substrates) agreed with half-life esti-
mates derived from SDS–PAGE and densitom-
etry, including independent data obtained from
the literature (Herman et al. 2005; Takagi et al.
2003). Baderschneider et al. (2002) also vali-
dated the SDS–PAGE and densitometry analy-
sis using an alternate analytical method
(HPLC). Together these studies indicate that a
kinetic approach to characterizing stability in
SGF is robust to typical variations that might
occur in the digestion procedure and, unlike
the time-to-disappearance approach, indepen-
dent of the method used to track protein decay.
Assay Relevance
A final requirement for a valid assay is rele-
vance to the property that is of interest. Three
aspects related to the relevance of SGF assay
results are discussed here: accuracy of tracking
in vitro stability in SGF, relevance to in vivo
stability, and correlation with allergenicity.
The ﬁrst level of relevance is the ability of
the assay to reﬂect the stability of a substrate
protein in the SGF assay. The alignment of the
kinetic interpretation of data with established
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Figure 1. Stability of different lots of pepsin: half-
lives for the reporter substrates DQ ovalbumin
(50 µg/mL) and azocoll (500 µg/mL) when exposed
to five different batches (lots) of pepsin in SGF.
Each lot of pepsin was of different purity (as indi-
cated) and was adjusted to 0.32% wt/vol. Data are
from Herman et al. (2005).
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Figure 2. Protein stability to different pepsin con-
centrations: half-lives for the reporter substrates
DQ ovalbumin (50 µg/mL) and azocoll (500 µg/mL)
when exposed to five different concentrations of
pepsin. Data are from Herman et al. (2005).Herman et al.
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enzyme and biodegradation literature (see ref-
erences in “Kinetic Data Analysis”), in combi-
nation with cross-validation studies on the
analytical procedures (Baderschneider et al.
2002; Herman et al. 2005), indicate that this
approach is relevant to protein stability in SGF.
A second aspect of relevance is how well
the SGF assay reflects stability in vivo. It is
widely acknowledged that the SGF assay may
not adequately simulate in vivo gastric diges-
tion, in part because in vivo digestion is inher-
ently variable across individuals and within
individuals over time (e.g., Bannon et al. 2002;
Burnett et al. 2002; Chikwamba et al. 2003;
Mendelsohn et al. 2003). Although mimicry is
not required for this assay, it should, at a mini-
mum, index a relevant process, in this case
in vivo stability of the protein before presenta-
tion to the immune system. However, data
exist indicating that highly SGF-digestible pro-
teins can induce immune responses (Dearman
et al. 2002; Kimber and Dearman 2002) and
survive in vivo digestion intact or as digestion
fragments (Chowdhury et al. 2003, Lutz et al.
2005), but data are not yet extensive enough to
reach a ﬁnal conclusion on the relevance of the
SGF assay to in vivo stability.
A third and most important level of rele-
vance is how well SGF assay results correlate
with allergenicity. It is generally acknowledged
that SGF stability results are an imperfect pre-
dictor of allergenic potential (e.g., Bannon et al.
2002, 2003; Fu et al. 2002; Goodman et al.
2005; Metcalfe 2005; Thomas et al. 2004).
This is true regardless of whether one considers
the most stable digestion fragment and protein
fraction or only the parent protein substrate.
Although some studies support a correlation
between stability in SGF and allergenicity (e.g.,
Astwood et al. 1996; Koppelman et al. 2005;
van Ree 2002), other studies show a poor rela-
tionship (e.g., Diaz-Perales et al. 2003; Fu et al.
2002; Herman et al. 2004; Lee et al. 2005;
Metcalfe 2005; Murtagh et al. 2002; Vieths
et al. 1999; Yagami et al. 2000). This inconsis-
tency has been largely attributed to a lack of
standardized methods (e.g., Bannon et al. 2002,
2003; Metcalfe 2005; Thomas et al. 2004), but
it is clear that other factors also contribute to
the disparate ﬁndings.
Although purified samples of transgenic
proteins are tested for biochemical and biologi-
cal equivalence to plant-produced proteins
(Fuchs et al. 1993; Gao et al. 2004; Gustafson
et al. 1997), reference allergens and non-
allergens typically have not been subjected to
this level of rigor. This may result in unde-
tected structural changes to reference proteins
during puriﬁcation that alter their susceptibil-
ity to proteases [e.g., chemically reduced state
of peanut allergen Ara h 2 (Sen et al. 2002;
Thomas et al. 2004) and heat denaturation
(Takagi et al. 2003)]. In addition, the array of
proteins and protein types that are chosen for
inclusion in a validation study can bias inter-
pretation (Fu et al. 2002). Clearly, there are
many examples of pepsin-unstable allergens
and pepsin-stable nonallergens (e.g., Diaz-
Perales et al. 2003; Fu et al. 2002; Herman
et al. 2004; Lee et al. 2005; Murtagh et al.
2002; Vieths et al. 1999; Yagami et al. 2000).
One potential explanation for the allergenicity
of pepsin-unstable proteins is possible absorp-
tion in the mouth. Absorption by the buccal
mucosa would bypass exposure to gastric ﬂuid
(Dirks et al. 2005; Poulsen 2005). A second
possible explanation for survival of pepsin-
labile proteins is that components of the food
matrix shield certain proteins from the gastric
environment (Chikwamba et al. 2003).
Multiple modifications of the standard
SGF recipe (Astwood et al. 1996; U.S.
Pharmacopeia 2000) have been proposed and
used to evaluate allergenicity potential (e.g.,
Reed et al. 1996; Takagi et al. 2003; Thomas
et al. 2004); however, no improvement in the
predictive power of these modiﬁed assays has
been reported. If modifications to the SGF
recipe are to be adopted, we suggest that they
not only should be theoretically appealing 
but also should be accompanied by empirical
data supporting the improved relevance of the
modiﬁed assay to allergenicity assessment.
Summary
Although there is growing evidence that the
SGF assay design and analysis can be standard-
ized so that results are both reproducible and
robust, the relevance of the assay to both in vivo
digestion and allergenic potential remains
uncertain. It is generally accepted that SGF sta-
bility should be considered in the weight-of-
evidence assessment of allergenic potential, but
it should be weighted lower than the source of
the gene and structural similarity with known
allergens (Lewis et al. 2005). Although some
data are now available using kinetic analyses
(Baderschneider et al. 2002; Herman et al.
2003, 2004, 2005; Takagi et al. 2003), addi-
tional kinetic results for well-characterized
preparations of known allergens and nonaller-
gens will need to be evaluated in the SGF assay
using appropriate analytical methods and inter-
pretation before the true predictive value of this
assay is understood.
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